Children with Cystic Fibrosis Have Prolonged Chemical Clearance of Acid Reflux Compared to Symptomatic Children Without Cystic Fibrosis

Overview

Journal Dig Dis Sci

Specialty Gastroenterology

Date 2013 Nov 30

PMID 24287640

Citations 9

Authors

Frederick W Woodley

Rodrigo S Machado

Don Hayes Jr

Carlo Di Lorenzo

Ajay Kaul

Beth Skaggs

Karen McCoy

Alpa Patel

Hayat Mousa

Affiliations

Soon will be listed here.

Abstract

Objectives: Few studies compare gastroesophageal reflux (GER) parameters of cystic fibrosis (CF) children and symptomatic non-CF children. We aimed to compare the impedance-pH (IMP-pH) parameters for these two groups and to test the hypothesis that prolonged acid exposure in CF patients is due to delayed chemical clearance (CC).

Methods: IMP-pH tracings from 16 CF children (median 8.2 years) and 16 symptomatic non-CF children (median 8.3 years) were analyzed. Software was used to generate IMP-pH reports and parameter data were extracted. IMP-pH was used to calculate the mean CC for each patient.

Results: pH studies showed no difference in acid GER (AGER) frequency (p = 0.587); however, mean AGER duration, duration of longest AGER, AGER index, and DeMeester scores were all significantly higher for CF patients. IMP showed no difference in GER frequency [neither acidic (p = 0.918) nor non-acidic (p = 0.277)], but total bolus clearance was more efficient in CF patients (p = 0.049). A larger percentage of total GER reached the proximal esophagus in non-CF children (p = 0.039). Analyses of two-phase AGER episodes showed that these events were more acidic (p = 0.003) and the CC phase was significantly prolonged in the CF cohort (p = 0.001).

Conclusions: Compared to symptomatic non-CF children, CF children do not have more frequent reflux. Actually, they have better bolus clearance efficiency following reflux and may even have better control over the number of GER episodes that reach the proximal esophagus. CC of AGER, however, is significantly prolonged in the CF cohort, likely due to hyperacidity of refluxed gastric contents.

Citing Articles

Neurogastroenterology and Motility Disorders of the Gastrointestinal Tract in Cystic Fibrosis.

Patel D, Jose F, Baker J, Moshiree B Curr Gastroenterol Rep. 2023; 26(1):9-19.

PMID: 38057499 DOI: 10.1007/s11894-023-00906-4.

Combined multi-channel intraluminal impedance measurement and pHmetry in the detection of gastroesophageal reflux disease in children with cystic fibrosis.

Goncalves E, Ribeiro J, Marson F, Montes C, Ribeiro A, Mainz J J Pediatr (Rio J). 2022; 99(3):269-277.

PMID: 36564006 PMC: 10202732. DOI: 10.1016/j.jped.2022.11.007.

Current therapies for gastro-oesophageal reflux in the setting of chronic lung disease: state of the art review.

McDonnell M, Hunt E, Ward C, Pearson J, OToole D, Laffey J ERJ Open Res. 2021; 6(4).

PMID: 33693049 PMC: 7927787. DOI: 10.1183/23120541.00190-2019.

Focus on gastroesophageal reflux disease in patients with cystic fibrosis.

Bongiovanni A, Manti S, Parisi G, Papale M, Mule E, Rotolo N World J Gastroenterol. 2020; 26(41):6322-6334.

PMID: 33244195 PMC: 7656210. DOI: 10.3748/wjg.v26.i41.6322.

Gastroesophageal reflux in cystic fibrosis across the age spectrum.

Woodley F, Hayes Jr D, Kopp B, Moore-Clingenpeel M, Machado R, Nemastil C Transl Gastroenterol Hepatol. 2019; 4:69.

PMID: 31620651 PMC: 6789305. DOI: 10.21037/tgh.2019.08.11.

References

de Veer A, Bos J, Niezen-de Boer R, Bohmer C, Francke A . Symptoms of gastroesophageal reflux disease in severely mentally retarded people: a systematic review. BMC Gastroenterol. 2008; 8:23. PMC: 2435531. DOI: 10.1186/1471-230X-8-23. View

Trezise A, Buchwald M . In vivo cell-specific expression of the cystic fibrosis transmembrane conductance regulator. Nature. 1991; 353(6343):434-7. DOI: 10.1038/353434a0. View

Lidums I, Holloway R . Motility abnormalities in the columnar-lined esophagus. Gastroenterol Clin North Am. 1997; 26(3):519-31. DOI: 10.1016/s0889-8553(05)70311-3. View

Kim B, Choi S, Kim J, Rhee J, Rhee P . Pathological bolus exposure plays a significant role in eliciting non-cardiac chest pain. J Gastroenterol Hepatol. 2010; 25(12):1855-60. DOI: 10.1111/j.1440-1746.2010.06415.x. View

Kellogg Jr D, Hodges G, Orozco C, Phillips T, Zhao J, Johnson J . Cholinergic mechanisms of cutaneous active vasodilation during heat stress in cystic fibrosis. J Appl Physiol (1985). 2007; 103(3):963-8. DOI: 10.1152/japplphysiol.00278.2007. View

Brodzicki J, Trawinska-Bartnicka M, Korzon M . Frequency, consequences and pharmacological treatment of gastroesophageal reflux in children with cystic fibrosis. Med Sci Monit. 2002; 8(7):CR529-37. View

BLOMFIELD J, van Lennep E, Shorey C, Malin A, Dascalu J, Brown J . Ultrastructure of the in vitro formation of hydroxyapatite in submandibular saliva of children with cystic fibrosis. Arch Oral Biol. 1974; 19(12):1153-60. DOI: 10.1016/0003-9969(74)90244-1. View

Zheng W, Kuhlicke J, Jackel K, Eltzschig H, Singh A, Sjoblom M . Hypoxia inducible factor-1 (HIF-1)-mediated repression of cystic fibrosis transmembrane conductance regulator (CFTR) in the intestinal epithelium. FASEB J. 2008; 23(1):204-13. PMC: 2626614. DOI: 10.1096/fj.08-110221. View

Aps J, Delanghe J, Martens L . Salivary electrolyte concentrations are associated with cystic fibrosis transmembrane regulator genotypes. Clin Chem Lab Med. 2002; 40(4):345-50. DOI: 10.1515/CCLM.2002.055. View

10.

Davies H, Bagg J, Goodchild M, McPherson M . Defective regulation of electrolyte and protein secretion in submandibular saliva of cystic fibrosis patients. Acta Paediatr Scand. 1991; 80(11):1094-5. DOI: 10.1111/j.1651-2227.1991.tb11789.x. View

11.

Cucchiara S, Santamaria F, Andreotti M, Minella R, Ercolini P, Oggero V . Mechanisms of gastro-oesophageal reflux in cystic fibrosis. Arch Dis Child. 1991; 66(5):617-22. PMC: 1792926. DOI: 10.1136/adc.66.5.617. View

12.

Ruigomez A, Wallander M, Lundborg P, Johansson S, Garcia Rodriguez L . Gastroesophageal reflux disease in children and adolescents in primary care. Scand J Gastroenterol. 2009; 45(2):139-46. DOI: 10.3109/00365520903428606. View

13.

Ledson M, Tran J, Walshaw M . Prevalence and mechanisms of gastro-oesophageal reflux in adult cystic fibrosis patients. J R Soc Med. 1998; 91(1):7-9. PMC: 1296415. DOI: 10.1177/014107689809100103. View

14.

Woodley F, Hayes J, Mousa H . Acid gastroesophageal reflux in symptomatic infants is primarily a function of classic 2-phase and pH-only acid reflux event types. J Pediatr Gastroenterol Nutr. 2009; 48(5):550-8. DOI: 10.1097/MPG.0b013e318185dae7. View

15.

Ribeiro C, Paradiso A, Carew M, Shears S, Boucher R . Cystic fibrosis airway epithelial Ca2+ i signaling: the mechanism for the larger agonist-mediated Ca2+ i signals in human cystic fibrosis airway epithelia. J Biol Chem. 2005; 280(11):10202-9. DOI: 10.1074/jbc.M410617200. View

16.

Nakhoul N, Orlando R . Lumen-to-surface pH gradients in opossum and rabbit esophagi: role of submucosal glands. Am J Physiol Gastrointest Liver Physiol. 2000; 278(1):G113-20. DOI: 10.1152/ajpgi.2000.278.1.G113. View

17.

Goncalves A, Marson F, Mendonca R, Ribeiro J, Ribeiro A, Paschoal I . Saliva as a potential tool for cystic fibrosis diagnosis. Diagn Pathol. 2013; 8:46. PMC: 3621375. DOI: 10.1186/1746-1596-8-46. View

18.

Ko S, Zeng W, Dorwart M, Luo X, Kim K, Millen L . Gating of CFTR by the STAS domain of SLC26 transporters. Nat Cell Biol. 2004; 6(4):343-50. PMC: 3943213. DOI: 10.1038/ncb1115. View

19.

Scott R, OLoughlin E, Gall D . Gastroesophageal reflux in patients with cystic fibrosis. J Pediatr. 1985; 106(2):223-7. DOI: 10.1016/s0022-3476(85)80291-2. View

20.

Blondeau K, Pauwels A, Dupont L, Mertens V, Proesmans M, Orel R . Characteristics of gastroesophageal reflux and potential risk of gastric content aspiration in children with cystic fibrosis. J Pediatr Gastroenterol Nutr. 2009; 50(2):161-6. DOI: 10.1097/MPG.0b013e3181acae98. View